<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Ovation Science</title>
	<atom:link href="https://ovationscience.com/feed/" rel="self" type="application/rss+xml" />
	<link>https://ovationscience.com/</link>
	<description>High-quality Cannabis Products</description>
	<lastBuildDate>Wed, 07 Jan 2026 13:10:10 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9</generator>
	<item>
		<title>Ovation Science Secures New Canadian Patent; Strengthening IP Position and Expanding Commercial Opportunities for Topical Cannabis Products</title>
		<link>https://ovationscience.com/ovation-science-secures-new-canadian-patent/</link>
					<comments>https://ovationscience.com/ovation-science-secures-new-canadian-patent/#respond</comments>
		
		<dc:creator><![CDATA[OS Admin]]></dc:creator>
		<pubDate>Wed, 07 Jan 2026 12:56:00 +0000</pubDate>
				<category><![CDATA[In the press]]></category>
		<guid isPermaLink="false">https://ovationscience.com/?p=2039</guid>

					<description><![CDATA[<p>The patent, entitled “Composition and method for transdermal delivery of cannabidiol (CBD) and delta9-tetrahydrocannabinol (THC)” expands Ovation’s intellectual property protection beyond its previously issued U.S. patent and significantly strengthens the Company’s growing international patent portfolio.</p>
<p>The post <a href="https://ovationscience.com/ovation-science-secures-new-canadian-patent/">Ovation Science Secures New Canadian Patent; Strengthening IP Position and Expanding Commercial Opportunities for Topical Cannabis Products</a> appeared first on <a href="https://ovationscience.com">Ovation Science</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ovationscience.com/ovation-science-secures-new-canadian-patent/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Ovation Science Sees Expanded Opportunities for Its Topical Products Following U.S. Cannabis Rescheduling</title>
		<link>https://ovationscience.com/expanded-opportunities-for-its-topical-products-following-u-s-cannabis-rescheduling/</link>
					<comments>https://ovationscience.com/expanded-opportunities-for-its-topical-products-following-u-s-cannabis-rescheduling/#respond</comments>
		
		<dc:creator><![CDATA[OS Admin]]></dc:creator>
		<pubDate>Mon, 22 Dec 2025 19:13:15 +0000</pubDate>
				<category><![CDATA[In the press]]></category>
		<guid isPermaLink="false">https://ovationscience.com/?p=2035</guid>

					<description><![CDATA[<p>Ovation Science Inc. (CSE: OVAT) is positioned to benefit from U.S. cannabis rescheduling, which reduces regulatory barriers for cannabinoid-based topicals. The company's patented Invisicare® technology delivers 82% CBD bioavailability—far exceeding the 2–3% of competing topicals—and its THC-free formulations may qualify for potential Medicare reimbursement, creating expanded licensing opportunities in the U.S. market.</p>
<p>The post <a href="https://ovationscience.com/expanded-opportunities-for-its-topical-products-following-u-s-cannabis-rescheduling/">Ovation Science Sees Expanded Opportunities for Its Topical Products Following U.S. Cannabis Rescheduling</a> appeared first on <a href="https://ovationscience.com">Ovation Science</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ovationscience.com/expanded-opportunities-for-its-topical-products-following-u-s-cannabis-rescheduling/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Ovation Science Inc. Closes Private Placement</title>
		<link>https://ovationscience.com/private-placement-oct-20-2025/</link>
		
		<dc:creator><![CDATA[OS Admin]]></dc:creator>
		<pubDate>Tue, 21 Oct 2025 00:08:44 +0000</pubDate>
				<category><![CDATA[In the press]]></category>
		<guid isPermaLink="false">https://ovationscience.com/?p=2024</guid>

					<description><![CDATA[<p>Ovation Science Inc. completed a non-brokered private placement to strengthen its financial position and support ongoing business development. The offering consisted of units made up of one common share and one warrant, with proceeds directed toward advancing company initiatives and general operations.</p>
<p>The post <a href="https://ovationscience.com/private-placement-oct-20-2025/">Ovation Science Inc. Closes Private Placement</a> appeared first on <a href="https://ovationscience.com">Ovation Science</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Ovation Science Inc. Announces Private Placement</title>
		<link>https://ovationscience.com/private-placement-sep-29-2025/</link>
		
		<dc:creator><![CDATA[OS Admin]]></dc:creator>
		<pubDate>Tue, 30 Sep 2025 00:28:28 +0000</pubDate>
				<category><![CDATA[In the press]]></category>
		<guid isPermaLink="false">https://ovationscience.com/?p=2026</guid>

					<description><![CDATA[<p>Ovation Science Inc. announced a non-brokered private placement to support its business growth and general working capital needs. The offering includes units comprised of one common share and one warrant, with finder’s fees payable in cash and warrants.</p>
<p>The post <a href="https://ovationscience.com/private-placement-sep-29-2025/">Ovation Science Inc. Announces Private Placement</a> appeared first on <a href="https://ovationscience.com">Ovation Science</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Ovation Science and Skinvisible Strengthen Partnership in Obesity Market with New Cannabinoid Delivery Patents</title>
		<link>https://ovationscience.com/strengthens-partnership-in-obesity-market/</link>
		
		<dc:creator><![CDATA[OS Admin]]></dc:creator>
		<pubDate>Thu, 18 Sep 2025 07:55:08 +0000</pubDate>
				<category><![CDATA[In the press]]></category>
		<guid isPermaLink="false">https://ovationscience.com/?p=2016</guid>

					<description><![CDATA[<p>Ovation Science and Skinvisible Pharmaceuticals have expanded their partnership to advance patent-pending Invisicare® cannabinoid delivery technology for obesity and metabolic health. The collaboration leverages THC-V research, new patent protection, and the growing US$150B obesity therapy market.</p>
<p>The post <a href="https://ovationscience.com/strengthens-partnership-in-obesity-market/">Ovation Science and Skinvisible Strengthen Partnership in Obesity Market with New Cannabinoid Delivery Patents</a> appeared first on <a href="https://ovationscience.com">Ovation Science</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Ovation Science Expands with Planet 13 into Florida</title>
		<link>https://ovationscience.com/planet-13-florida-expansion/</link>
		
		<dc:creator><![CDATA[OS Admin]]></dc:creator>
		<pubDate>Tue, 29 Jul 2025 07:00:20 +0000</pubDate>
				<category><![CDATA[In the press]]></category>
		<guid isPermaLink="false">https://ovationscience.com/?p=2009</guid>

					<description><![CDATA[<p>Ovation Science Inc. announced an expanded license agreement with Planet 13 Holdings to bring its patented Invisicare® topical cannabis products to Florida's medical cannabis market. The products will be available across Planet 13's 33 Florida dispensary locations, marking Ovation's third active market alongside Nevada and Pennsylvania, with additional 2025 expansions planned in Missouri and Canada.</p>
<p>The post <a href="https://ovationscience.com/planet-13-florida-expansion/">Ovation Science Expands with Planet 13 into Florida</a> appeared first on <a href="https://ovationscience.com">Ovation Science</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Your Body Called, It Wants Its Mojo Back</title>
		<link>https://ovationscience.com/your-body-called-it-wants-its-mojo-back/</link>
		
		<dc:creator><![CDATA[OS Admin]]></dc:creator>
		<pubDate>Wed, 09 Jul 2025 16:07:22 +0000</pubDate>
				<category><![CDATA[In the press]]></category>
		<category><![CDATA[Latest Publications]]></category>
		<guid isPermaLink="false">https://ovationscience.com/?p=2001</guid>

					<description><![CDATA[<p>As recently featured in Wellness Master Club Magazine, Invibe®MD is redefining wellness with a science-backed, transdermal approach that goes beyond surface-level fixes.</p>
<p>The post <a href="https://ovationscience.com/your-body-called-it-wants-its-mojo-back/">Your Body Called, It Wants Its Mojo Back</a> appeared first on <a href="https://ovationscience.com">Ovation Science</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Ovation Science Licensee Launches Innovative Transdermal Cannabis Products in Pennsylvania</title>
		<link>https://ovationscience.com/licensee-launches-innovative-transdermal-cannabis-products-in-pennsylvania/</link>
		
		<dc:creator><![CDATA[OS Admin]]></dc:creator>
		<pubDate>Wed, 04 Dec 2024 13:00:20 +0000</pubDate>
				<category><![CDATA[In the press]]></category>
		<category><![CDATA[Latest Publications]]></category>
		<guid isPermaLink="false">https://ovationscience.com/?p=1991</guid>

					<description><![CDATA[<p>Ovation Science Inc. launches its patented cannabis products in Pennsylvania through PA Options for Wellness, offering advanced transdermal and topical solutions powered by Invisicare® technology. With over 850,000 registered medical cannabis patients, this collaboration enhances patient care with research-backed, highly effective cannabinoid delivery systems.</p>
<p>The post <a href="https://ovationscience.com/licensee-launches-innovative-transdermal-cannabis-products-in-pennsylvania/">Ovation Science Licensee Launches Innovative Transdermal Cannabis Products in Pennsylvania</a> appeared first on <a href="https://ovationscience.com">Ovation Science</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Ovation Science Topicals Launch with Planet 13 in Nevada</title>
		<link>https://ovationscience.com/topicals-launch-with-planet-13/</link>
		
		<dc:creator><![CDATA[OS Admin]]></dc:creator>
		<pubDate>Tue, 30 Apr 2024 10:35:03 +0000</pubDate>
				<category><![CDATA[In the press]]></category>
		<guid isPermaLink="false">https://ovationscience.com/?p=1976</guid>

					<description><![CDATA[<p>Ovation Science announced the official launch of Ovation's topical product line in Nevada. These products, powered by Ovation's patented skin delivery technology, will be available in-store at Planet 13's SuperStore and online. The partnership aims to expand Planet 13's product offerings and leverage its production facility to manufacture the cannabis-derived topicals.</p>
<p>The post <a href="https://ovationscience.com/topicals-launch-with-planet-13/">Ovation Science Topicals Launch with Planet 13 in Nevada</a> appeared first on <a href="https://ovationscience.com">Ovation Science</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Ovation Science Expands Market Reach with Exclusive Canadian License Agreement</title>
		<link>https://ovationscience.com/ripco-license-agreement/</link>
		
		<dc:creator><![CDATA[OS Admin]]></dc:creator>
		<pubDate>Thu, 11 Apr 2024 12:00:06 +0000</pubDate>
				<category><![CDATA[In the press]]></category>
		<guid isPermaLink="false">https://ovationscience.com/?p=1971</guid>

					<description><![CDATA[<p>Ovation Science announced the signing of an exclusive licensing agreement for Ovation’s products for Canada with Ripco Processing Inc. a company based in Calgary, Alberta and founded by successful legal cannabis pioneers.</p>
<p>The post <a href="https://ovationscience.com/ripco-license-agreement/">Ovation Science Expands Market Reach with Exclusive Canadian License Agreement</a> appeared first on <a href="https://ovationscience.com">Ovation Science</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
